Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits

Clinical Orthopaedics and Related Research

Volumn 359, Issue , 1999, Pages 229-236

  Shirtliff, Mark E ^b   Mader, Jon T ^a,b   Calhoun, Jason ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; MACROLIDE; NAFCILLIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; ARTICLE; BONE LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MIXTURE; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOMYELITIS; PRIORITY JOURNAL; RABBIT; STAPHYLOCOCCUS AUREUS; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0033023318     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199902000-00026     Document Type: Article

References (30)

1. Cierny G, Mader JT: Adult chronic osteomyelitis. Orthopedics 7:1557-1564, 1984.
2. Couch L, Cierny G, Mader JT: Inpatient and outpatient use of the Hickman catheter for adults with osteomyelitis. Clin Orthop 219:226-235, 1987.
3. Dabernat H, Delmas C, Seguy M, et al: The activity of clarithromycin and its 14-hydroxy metabolite against Haemophilus influcnzae determined by in vitro and serum bactericidal tests. J Antimicrob Chemother 27(Suppl A):19-30, 1991.
4. Daum TE, Schaberg DR, Terpenning MS, Sottile WS, Kauffman CA: Increasing resistance of Staphylococcus aureus to ciprofloxacin. Antimicrob Agents Chemother 34:1862-1863, 1990.
5. Drancourt M, Stein A, Argenson JN, et al: Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob Agents Chemother 37:1214-1218, 1993.
6. Dworkin RJ, Sande MA, Lee BL, Chambers HF: Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet 2:1071-1074, 1989.
7. Ericcson HM, Sherris JC: Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand 217(Sect B Suppl):1-90, 1971.
8. Farr B, Mandell GL: Rifampin. In Mandell GL, Douglas RG, Bennett JE (eds). Antimicrobial Therapy. New York, John Wiley and Sons, Inc 175-184, 1985.
9. Foulds G, Shepard RM, Johnson RB: The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 25(Suppl A):473-482, 1990.
10. Graham DR, Keldermans MM, Klemm LW, Semenza NJ, Shafer ML: Infectious complications among patients receiving home intravenous therapy with peripheral, central, or peripherally placed central venous catheters. Am J Med 91(Suppl):95-100, 1991.
11. Hickman RO, Buckner CD, Clift RA, et al: A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 148:871-875, 1979.
12. Lagast H, Husson M, Klastersky J: Bactericidal activity of ciprofloxacin in serum and urine against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Streptococcus faecalis. J Antimicrob Chemother 16:341-347, 1985.
13. Lode H: The pharmacokinetics of azithromycin and their clinical significance. Eur J Clin Microbiol Infect Dis 10:807-812, 1991.
14. Mader JT: Animal models of osteomyelitis. Am J Med 78(Suppl B):213-217, 1985.
15. Mader JT: Fluoroquinolones in Bone and Joint Infections. In Sanders Jr WE, Sanders CC (eds). Fluoroquinolones in the Treatment of Infectious Diseases. Glenview, IL, Physicians & Scientists Publishing Co Inc 71-86, 1990.
16. Mader JT, Cantrell JS, Calhoun JH: Oral ciprofloxacin versus standard parenteral antibiotic therapy for adult chronic osteomyelitis. J Bone Joint Surg 72A:104-110, 1990.
17. Mader JT, Morrison LT, Adams KR: Comparative evaluation of A-56620, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis. Antimicrob Agents Chemother 31:259-263, 1987.
18. Mader JT, Wilson KJ: Comparative evaluation of cefamandole and cephalothin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits. J Bone Joint Surg 65A:507-513, 1983.
19. Marr JM, Gnam III EC, Calhoun JH, Mader JT: A non-stressful alternative to gastric lavage for oral administration of antibiotics in rabbits. Lab Anim 22:47-49, 1993.
20. McDonald PJ, Pruul H: Phagocyte uptake and transport of azithromycin. Eur J Clin Microbiol Infect Dis 10:828-833, 1991.
21. Neu HC: Clinical microbiology of azithromycin. Am J Med 91(Suppl 3A):12-18, 1991.
22. Norden CW, Kennedy E: Experimental osteomyelitis. I. A description of the model. J Infect Dis 122:410-418, 1970.
23. Norden CW, Shaffer M: Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with vancomycin and rifampin. J Infect Dis 147:352-357, 1983.
24. O'Reilly T, Kuntz S, Sande E, et al: Relationship between antibiotic concentration in bone and efficacy of the treatment of Staphylococcal osteomyelitis in rats: Azithromycin compared with clindamycin and rifampin. Antimicrob Agents Chemother 36:2693-2697, 1992.
25. Retsema JA, Brennan LA, Girard AE: Effects of environmental factors on the in vitro potency of azithromycin. Eur J Clin Microbiol Infect Dis 10:834-842, 1991.
26. Retsema JA, Girard AE, Girard D, Millisen WB: Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo. J Antimicrob Chemother 25(Suppl A):83-89, 1990.
27. Takeda H, Oogaki N, Kikuchi N, Kobayashi N, Akashi T: A study to clarify the mechanisms of the usefulness of macrolides. The influences of clarithromycin on biofilm with P. aeruginosa. J Jpn Assoc Infect Dis 66:1454-1461, 1992.
28. Waldvogel FA, Medoff G, Swartz MN: Osteomyelitis: A review of clinical features, therapeutic considerations and unusual aspects. N Engl J Med 282:198-206, 260-266, 316-322, 1970.
29. Williams JD: Spectrum of activity of azithromycin. Eur J Clin Microbiol Infect Dis 10:813-820, 1991.
30. Yasuda H, Ajiki Y, Koga T, Yokota T: Interaction between clarithromycin and biofilms formed by Staphylococcus epidermidis. Antimicrob Agents Chemother 38:138-141, 1994.